nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN3A—spinal nerve—multiple sclerosis	0.0912	0.217	CbGeAlD
Mepivacaine—SCN8A—peripheral nervous system—multiple sclerosis	0.0369	0.0878	CbGeAlD
Mepivacaine—SCN8A—nerve—multiple sclerosis	0.0288	0.0684	CbGeAlD
Mepivacaine—SCN10A—peripheral nervous system—multiple sclerosis	0.0247	0.0587	CbGeAlD
Mepivacaine—SCN10A—nerve—multiple sclerosis	0.0193	0.0458	CbGeAlD
Mepivacaine—SCN8A—brainstem—multiple sclerosis	0.0124	0.0294	CbGeAlD
Mepivacaine—SCN1A—brainstem—multiple sclerosis	0.00935	0.0222	CbGeAlD
Mepivacaine—SCN2A—brainstem—multiple sclerosis	0.00858	0.0204	CbGeAlD
Mepivacaine—SCN8A—L1CAM interactions—CD24—multiple sclerosis	0.00802	0.0656	CbGpPWpGaD
Mepivacaine—Cardiac arrest—Fingolimod—multiple sclerosis	0.00769	0.0168	CcSEcCtD
Mepivacaine—SCN8A—spinal cord—multiple sclerosis	0.00769	0.0183	CbGeAlD
Mepivacaine—Meningitis—Dexamethasone—multiple sclerosis	0.00733	0.0161	CcSEcCtD
Mepivacaine—Meningitis—Betamethasone—multiple sclerosis	0.00733	0.0161	CcSEcCtD
Mepivacaine—SCN9A—midbrain—multiple sclerosis	0.00692	0.0164	CbGeAlD
Mepivacaine—SCN9A—spinal cord—multiple sclerosis	0.00676	0.016	CbGeAlD
Mepivacaine—SCN1A—medulla oblongata—multiple sclerosis	0.00652	0.0155	CbGeAlD
Mepivacaine—SCN9A—L1CAM interactions—CD24—multiple sclerosis	0.00649	0.0531	CbGpPWpGaD
Mepivacaine—SCN8A—nervous system—multiple sclerosis	0.00648	0.0154	CbGeAlD
Mepivacaine—Meningitis—Prednisone—multiple sclerosis	0.00639	0.014	CcSEcCtD
Mepivacaine—SCN8A—central nervous system—multiple sclerosis	0.00624	0.0148	CbGeAlD
Mepivacaine—SCN3A—L1CAM interactions—CD24—multiple sclerosis	0.00621	0.0508	CbGpPWpGaD
Mepivacaine—SCN8A—cerebellum—multiple sclerosis	0.0061	0.0145	CbGeAlD
Mepivacaine—SCN2A—medulla oblongata—multiple sclerosis	0.00598	0.0142	CbGeAlD
Mepivacaine—SCN2A—L1CAM interactions—CD24—multiple sclerosis	0.00596	0.0488	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—CD24—multiple sclerosis	0.00596	0.0488	CbGpPWpGaD
Mepivacaine—SCN1A—midbrain—multiple sclerosis	0.00596	0.0142	CbGeAlD
Mepivacaine—SCN1A—spinal cord—multiple sclerosis	0.00581	0.0138	CbGeAlD
Mepivacaine—SCN10A—L1CAM interactions—CD24—multiple sclerosis	0.00575	0.047	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—CD24—multiple sclerosis	0.00575	0.047	CbGpPWpGaD
Mepivacaine—Bradycardia—Fingolimod—multiple sclerosis	0.0057	0.0125	CcSEcCtD
Mepivacaine—Sneezing—Triamcinolone—multiple sclerosis	0.00566	0.0124	CcSEcCtD
Mepivacaine—SCN2A—midbrain—multiple sclerosis	0.00547	0.013	CbGeAlD
Mepivacaine—SCN2A—spinal cord—multiple sclerosis	0.00533	0.0127	CbGeAlD
Mepivacaine—SCN3A—medulla oblongata—multiple sclerosis	0.00526	0.0125	CbGeAlD
Mepivacaine—Swelling—Cladribine—multiple sclerosis	0.0052	0.0114	CcSEcCtD
Mepivacaine—SCN10A—spinal cord—multiple sclerosis	0.00514	0.0122	CbGeAlD
Mepivacaine—SCN4A—nervous system—multiple sclerosis	0.00508	0.0121	CbGeAlD
Mepivacaine—SCN8A—brain—multiple sclerosis	0.00495	0.0118	CbGeAlD
Mepivacaine—SCN1A—nervous system—multiple sclerosis	0.0049	0.0116	CbGeAlD
Mepivacaine—SCN4A—central nervous system—multiple sclerosis	0.00489	0.0116	CbGeAlD
Mepivacaine—SCN3A—midbrain—multiple sclerosis	0.0048	0.0114	CbGeAlD
Mepivacaine—SCN1A—central nervous system—multiple sclerosis	0.00471	0.0112	CbGeAlD
Mepivacaine—Back pain—Fingolimod—multiple sclerosis	0.00471	0.0103	CcSEcCtD
Mepivacaine—SCN3A—spinal cord—multiple sclerosis	0.00469	0.0111	CbGeAlD
Mepivacaine—SCN1A—cerebellum—multiple sclerosis	0.00461	0.0109	CbGeAlD
Mepivacaine—Vision blurred—Fingolimod—multiple sclerosis	0.00459	0.0101	CcSEcCtD
Mepivacaine—SCN2A—nervous system—multiple sclerosis	0.00449	0.0107	CbGeAlD
Mepivacaine—SCN9A—brain—multiple sclerosis	0.00435	0.0103	CbGeAlD
Mepivacaine—SCN10A—nervous system—multiple sclerosis	0.00433	0.0103	CbGeAlD
Mepivacaine—SCN2A—central nervous system—multiple sclerosis	0.00433	0.0103	CbGeAlD
Mepivacaine—SCN2A—cerebellum—multiple sclerosis	0.00423	0.01	CbGeAlD
Mepivacaine—Hypertension—Fingolimod—multiple sclerosis	0.00421	0.00921	CcSEcCtD
Mepivacaine—SCN10A—central nervous system—multiple sclerosis	0.00417	0.00991	CbGeAlD
Mepivacaine—SCN5A—L1CAM interactions—CD24—multiple sclerosis	0.00404	0.0331	CbGpPWpGaD
Mepivacaine—SCN3A—nervous system—multiple sclerosis	0.00395	0.00938	CbGeAlD
Mepivacaine—SCN5A—nervous system—multiple sclerosis	0.00394	0.00936	CbGeAlD
Mepivacaine—SCN4A—brain—multiple sclerosis	0.00388	0.00922	CbGeAlD
Mepivacaine—Sweating increased—Cladribine—multiple sclerosis	0.00386	0.00845	CcSEcCtD
Mepivacaine—SCN3A—central nervous system—multiple sclerosis	0.0038	0.00903	CbGeAlD
Mepivacaine—SCN5A—central nervous system—multiple sclerosis	0.00379	0.00901	CbGeAlD
Mepivacaine—SCN1A—brain—multiple sclerosis	0.00374	0.00889	CbGeAlD
Mepivacaine—SCN3A—cerebellum—multiple sclerosis	0.00372	0.00883	CbGeAlD
Mepivacaine—Hypotension—Fingolimod—multiple sclerosis	0.00372	0.00814	CcSEcCtD
Mepivacaine—Paraesthesia—Fingolimod—multiple sclerosis	0.00357	0.00782	CcSEcCtD
Mepivacaine—SCN2A—brain—multiple sclerosis	0.00344	0.00816	CbGeAlD
Mepivacaine—Swelling—Mitoxantrone—multiple sclerosis	0.00342	0.00748	CcSEcCtD
Mepivacaine—SCN10A—brain—multiple sclerosis	0.00331	0.00787	CbGeAlD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00322	0.0264	CbGpPWpGaD
Mepivacaine—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.00312	0.00682	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—CD24—multiple sclerosis	0.00303	0.0248	CbGpPWpGaD
Mepivacaine—SCN3A—brain—multiple sclerosis	0.00302	0.00717	CbGeAlD
Mepivacaine—SCN5A—brain—multiple sclerosis	0.00301	0.00715	CbGeAlD
Mepivacaine—Paralysis—Methotrexate—multiple sclerosis	0.00298	0.00652	CcSEcCtD
Mepivacaine—Asthenia—Fingolimod—multiple sclerosis	0.00285	0.00625	CcSEcCtD
Mepivacaine—Chills—Cladribine—multiple sclerosis	0.00285	0.00623	CcSEcCtD
Mepivacaine—Pruritus—Fingolimod—multiple sclerosis	0.00281	0.00616	CcSEcCtD
Mepivacaine—Erythema—Cladribine—multiple sclerosis	0.00276	0.00605	CcSEcCtD
Mepivacaine—Back pain—Cladribine—multiple sclerosis	0.00267	0.00585	CcSEcCtD
Mepivacaine—Dizziness—Fingolimod—multiple sclerosis	0.00263	0.00576	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.00256	0.0056	CcSEcCtD
Mepivacaine—Sweating increased—Mitoxantrone—multiple sclerosis	0.00254	0.00556	CcSEcCtD
Mepivacaine—Headache—Fingolimod—multiple sclerosis	0.00249	0.00545	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—CD24—multiple sclerosis	0.00245	0.0201	CbGpPWpGaD
Mepivacaine—Apnoea—Methotrexate—multiple sclerosis	0.00244	0.00534	CcSEcCtD
Mepivacaine—Cardiac arrest—Prednisolone—multiple sclerosis	0.00235	0.00515	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00235	0.00515	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—CD24—multiple sclerosis	0.00235	0.0192	CbGpPWpGaD
Mepivacaine—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00234	0.00513	CcSEcCtD
Mepivacaine—Anxiety—Cladribine—multiple sclerosis	0.00234	0.00513	CcSEcCtD
Mepivacaine—Drowsiness—Mitoxantrone—multiple sclerosis	0.00232	0.00509	CcSEcCtD
Mepivacaine—Chills—Azathioprine—multiple sclerosis	0.00232	0.00507	CcSEcCtD
Mepivacaine—Oedema—Cladribine—multiple sclerosis	0.00225	0.00494	CcSEcCtD
Mepivacaine—SCN4A—Axon guidance—CD24—multiple sclerosis	0.00225	0.0184	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—CD24—multiple sclerosis	0.00225	0.0184	CbGpPWpGaD
Mepivacaine—Sweating—Mitoxantrone—multiple sclerosis	0.00223	0.00488	CcSEcCtD
Mepivacaine—Tachycardia—Cladribine—multiple sclerosis	0.0022	0.00482	CcSEcCtD
Mepivacaine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00218	0.00477	CcSEcCtD
Mepivacaine—SCN1A—Axon guidance—CD24—multiple sclerosis	0.00217	0.0178	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—CD24—multiple sclerosis	0.00217	0.0178	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CD24—multiple sclerosis	0.00216	0.0177	CbGpPWpGaD
Mepivacaine—Cardiac arrest—Triamcinolone—multiple sclerosis	0.00216	0.00474	CcSEcCtD
Mepivacaine—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00216	0.00472	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00213	0.00467	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00213	0.00467	CcSEcCtD
Mepivacaine—Bradycardia—Mitoxantrone—multiple sclerosis	0.00212	0.00465	CcSEcCtD
Mepivacaine—Hypotension—Cladribine—multiple sclerosis	0.00211	0.00461	CcSEcCtD
Mepivacaine—Sweating increased—Prednisolone—multiple sclerosis	0.00208	0.00456	CcSEcCtD
Mepivacaine—Paraesthesia—Cladribine—multiple sclerosis	0.00202	0.00443	CcSEcCtD
Mepivacaine—Somnolence—Cladribine—multiple sclerosis	0.002	0.00439	CcSEcCtD
Mepivacaine—Cardiac arrest—Betamethasone—multiple sclerosis	0.00196	0.0043	CcSEcCtD
Mepivacaine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00196	0.0043	CcSEcCtD
Mepivacaine—Sweating increased—Triamcinolone—multiple sclerosis	0.00192	0.00419	CcSEcCtD
Mepivacaine—Sweating increased—Methylprednisolone—multiple sclerosis	0.00191	0.00418	CcSEcCtD
Mepivacaine—Chills—Mitoxantrone—multiple sclerosis	0.00187	0.0041	CcSEcCtD
Mepivacaine—Erythema—Mitoxantrone—multiple sclerosis	0.00182	0.00398	CcSEcCtD
Mepivacaine—Urticaria—Cladribine—multiple sclerosis	0.00179	0.00392	CcSEcCtD
Mepivacaine—Body temperature increased—Cladribine—multiple sclerosis	0.00178	0.0039	CcSEcCtD
Mepivacaine—Back pain—Mitoxantrone—multiple sclerosis	0.00176	0.00385	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—CD24—multiple sclerosis	0.00175	0.0143	CbGpPWpGaD
Mepivacaine—Bradycardia—Prednisolone—multiple sclerosis	0.00174	0.00381	CcSEcCtD
Mepivacaine—Sweating increased—Dexamethasone—multiple sclerosis	0.00174	0.0038	CcSEcCtD
Mepivacaine—Sweating increased—Betamethasone—multiple sclerosis	0.00174	0.0038	CcSEcCtD
Mepivacaine—Hypotension—Azathioprine—multiple sclerosis	0.00171	0.00375	CcSEcCtD
Mepivacaine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00171	0.00375	CcSEcCtD
Mepivacaine—Cardiac arrest—Prednisone—multiple sclerosis	0.00171	0.00374	CcSEcCtD
Mepivacaine—Sweating—Methylprednisolone—multiple sclerosis	0.00168	0.00367	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—CD24—multiple sclerosis	0.00167	0.0137	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Cladribine—multiple sclerosis	0.00166	0.00364	CcSEcCtD
Mepivacaine—Asthenia—Cladribine—multiple sclerosis	0.00162	0.00354	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—CD24—multiple sclerosis	0.00161	0.0132	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CD24—multiple sclerosis	0.00161	0.0132	CbGpPWpGaD
Mepivacaine—Bradycardia—Triamcinolone—multiple sclerosis	0.0016	0.00351	CcSEcCtD
Mepivacaine—Bradycardia—Methylprednisolone—multiple sclerosis	0.0016	0.0035	CcSEcCtD
Mepivacaine—Pruritus—Cladribine—multiple sclerosis	0.0016	0.00349	CcSEcCtD
Mepivacaine—Convulsion—Mitoxantrone—multiple sclerosis	0.00157	0.00344	CcSEcCtD
Mepivacaine—Hypertension—Mitoxantrone—multiple sclerosis	0.00157	0.00343	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.00155	0.0034	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—CD24—multiple sclerosis	0.00155	0.0127	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CD24—multiple sclerosis	0.00155	0.0127	CbGpPWpGaD
Mepivacaine—Anxiety—Mitoxantrone—multiple sclerosis	0.00154	0.00337	CcSEcCtD
Mepivacaine—SCN5A—Axon guidance—CD24—multiple sclerosis	0.00153	0.0125	CbGpPWpGaD
Mepivacaine—Sweating increased—Prednisone—multiple sclerosis	0.00151	0.00331	CcSEcCtD
Mepivacaine—Dizziness—Cladribine—multiple sclerosis	0.00149	0.00326	CcSEcCtD
Mepivacaine—Erythema—Prednisolone—multiple sclerosis	0.00149	0.00326	CcSEcCtD
Mepivacaine—Oedema—Mitoxantrone—multiple sclerosis	0.00148	0.00324	CcSEcCtD
Mepivacaine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00148	0.00324	CcSEcCtD
Mepivacaine—Shock—Mitoxantrone—multiple sclerosis	0.00146	0.00319	CcSEcCtD
Mepivacaine—Bradycardia—Betamethasone—multiple sclerosis	0.00145	0.00318	CcSEcCtD
Mepivacaine—Bradycardia—Dexamethasone—multiple sclerosis	0.00145	0.00318	CcSEcCtD
Mepivacaine—Body temperature increased—Azathioprine—multiple sclerosis	0.00145	0.00317	CcSEcCtD
Mepivacaine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00145	0.00317	CcSEcCtD
Mepivacaine—Vomiting—Cladribine—multiple sclerosis	0.00143	0.00314	CcSEcCtD
Mepivacaine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00143	0.00314	CcSEcCtD
Mepivacaine—Headache—Cladribine—multiple sclerosis	0.00141	0.00309	CcSEcCtD
Mepivacaine—Vision blurred—Prednisolone—multiple sclerosis	0.0014	0.00307	CcSEcCtD
Mepivacaine—Hypotension—Mitoxantrone—multiple sclerosis	0.00138	0.00303	CcSEcCtD
Mepivacaine—Erythema—Triamcinolone—multiple sclerosis	0.00137	0.003	CcSEcCtD
Mepivacaine—Erythema—Methylprednisolone—multiple sclerosis	0.00137	0.00299	CcSEcCtD
Mepivacaine—Angioedema—Prednisolone—multiple sclerosis	0.00136	0.00298	CcSEcCtD
Mepivacaine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00135	0.00296	CcSEcCtD
Mepivacaine—Nausea—Cladribine—multiple sclerosis	0.00134	0.00293	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00134	0.0109	CbGpPWpGaD
Mepivacaine—Syncope—Prednisolone—multiple sclerosis	0.00134	0.00292	CcSEcCtD
Mepivacaine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00133	0.00291	CcSEcCtD
Mepivacaine—Back pain—Triamcinolone—multiple sclerosis	0.00133	0.0029	CcSEcCtD
Mepivacaine—Somnolence—Mitoxantrone—multiple sclerosis	0.00132	0.00288	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisolone—multiple sclerosis	0.00131	0.00287	CcSEcCtD
Mepivacaine—Convulsion—Prednisolone—multiple sclerosis	0.00129	0.00283	CcSEcCtD
Mepivacaine—Hypertension—Prednisolone—multiple sclerosis	0.00129	0.00282	CcSEcCtD
Mepivacaine—Bradycardia—Prednisone—multiple sclerosis	0.00127	0.00277	CcSEcCtD
Mepivacaine—Angioedema—Triamcinolone—multiple sclerosis	0.00125	0.00274	CcSEcCtD
Mepivacaine—Angioedema—Methylprednisolone—multiple sclerosis	0.00125	0.00273	CcSEcCtD
Mepivacaine—Erythema—Betamethasone—multiple sclerosis	0.00124	0.00272	CcSEcCtD
Mepivacaine—Erythema—Dexamethasone—multiple sclerosis	0.00124	0.00272	CcSEcCtD
Mepivacaine—Syncope—Triamcinolone—multiple sclerosis	0.00123	0.00269	CcSEcCtD
Mepivacaine—Syncope—Methylprednisolone—multiple sclerosis	0.00123	0.00268	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00122	0.00266	CcSEcCtD
Mepivacaine—Oedema—Prednisolone—multiple sclerosis	0.00122	0.00266	CcSEcCtD
Mepivacaine—Dizziness—Azathioprine—multiple sclerosis	0.00121	0.00265	CcSEcCtD
Mepivacaine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.0012	0.00264	CcSEcCtD
Mepivacaine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.0012	0.00263	CcSEcCtD
Mepivacaine—Shock—Prednisolone—multiple sclerosis	0.0012	0.00262	CcSEcCtD
Mepivacaine—Convulsion—Triamcinolone—multiple sclerosis	0.00119	0.0026	CcSEcCtD
Mepivacaine—Tachycardia—Prednisolone—multiple sclerosis	0.00119	0.0026	CcSEcCtD
Mepivacaine—Convulsion—Methylprednisolone—multiple sclerosis	0.00118	0.00259	CcSEcCtD
Mepivacaine—Hypertension—Triamcinolone—multiple sclerosis	0.00118	0.00259	CcSEcCtD
Mepivacaine—Hypertension—Methylprednisolone—multiple sclerosis	0.00118	0.00258	CcSEcCtD
Mepivacaine—Urticaria—Mitoxantrone—multiple sclerosis	0.00118	0.00258	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00118	0.00257	CcSEcCtD
Mepivacaine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00117	0.00256	CcSEcCtD
Mepivacaine—Vomiting—Azathioprine—multiple sclerosis	0.00117	0.00255	CcSEcCtD
Mepivacaine—Anxiety—Methylprednisolone—multiple sclerosis	0.00116	0.00254	CcSEcCtD
Mepivacaine—Drowsiness—Methotrexate—multiple sclerosis	0.00116	0.00253	CcSEcCtD
Mepivacaine—Headache—Azathioprine—multiple sclerosis	0.00115	0.00251	CcSEcCtD
Mepivacaine—Angioedema—Betamethasone—multiple sclerosis	0.00114	0.00249	CcSEcCtD
Mepivacaine—Angioedema—Dexamethasone—multiple sclerosis	0.00114	0.00249	CcSEcCtD
Mepivacaine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00112	0.00245	CcSEcCtD
Mepivacaine—Oedema—Triamcinolone—multiple sclerosis	0.00112	0.00245	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00112	0.00244	CcSEcCtD
Mepivacaine—Syncope—Dexamethasone—multiple sclerosis	0.00111	0.00244	CcSEcCtD
Mepivacaine—Syncope—Betamethasone—multiple sclerosis	0.00111	0.00244	CcSEcCtD
Mepivacaine—Sweating—Methotrexate—multiple sclerosis	0.00111	0.00243	CcSEcCtD
Mepivacaine—Shock—Triamcinolone—multiple sclerosis	0.0011	0.00241	CcSEcCtD
Mepivacaine—Shock—Methylprednisolone—multiple sclerosis	0.0011	0.0024	CcSEcCtD
Mepivacaine—Loss of consciousness—Betamethasone—multiple sclerosis	0.00109	0.00239	CcSEcCtD
Mepivacaine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00109	0.00239	CcSEcCtD
Mepivacaine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00109	0.00239	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisolone—multiple sclerosis	0.00109	0.00239	CcSEcCtD
Mepivacaine—Tachycardia—Triamcinolone—multiple sclerosis	0.00109	0.00239	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—CD24—multiple sclerosis	0.00109	0.00892	CbGpPWpGaD
Mepivacaine—Nausea—Azathioprine—multiple sclerosis	0.00109	0.00238	CcSEcCtD
Mepivacaine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00109	0.00238	CcSEcCtD
Mepivacaine—Erythema—Prednisone—multiple sclerosis	0.00108	0.00237	CcSEcCtD
Mepivacaine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00108	0.00237	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00108	0.00236	CcSEcCtD
Mepivacaine—Convulsion—Dexamethasone—multiple sclerosis	0.00108	0.00236	CcSEcCtD
Mepivacaine—Convulsion—Betamethasone—multiple sclerosis	0.00108	0.00236	CcSEcCtD
Mepivacaine—Hypertension—Betamethasone—multiple sclerosis	0.00107	0.00235	CcSEcCtD
Mepivacaine—Hypertension—Dexamethasone—multiple sclerosis	0.00107	0.00235	CcSEcCtD
Mepivacaine—Asthenia—Mitoxantrone—multiple sclerosis	0.00106	0.00233	CcSEcCtD
Mepivacaine—Anxiety—Dexamethasone—multiple sclerosis	0.00105	0.00231	CcSEcCtD
Mepivacaine—Anxiety—Betamethasone—multiple sclerosis	0.00105	0.00231	CcSEcCtD
Mepivacaine—Hypotension—Methylprednisolone—multiple sclerosis	0.00104	0.00228	CcSEcCtD
Mepivacaine—Vision blurred—Prednisone—multiple sclerosis	0.00102	0.00223	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.00101	0.0083	CbGpPWpGaD
Mepivacaine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00101	0.00222	CcSEcCtD
Mepivacaine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00101	0.00222	CcSEcCtD
Mepivacaine—Oedema—Dexamethasone—multiple sclerosis	0.00101	0.00222	CcSEcCtD
Mepivacaine—Oedema—Betamethasone—multiple sclerosis	0.00101	0.00222	CcSEcCtD
Mepivacaine—Paraesthesia—Triamcinolone—multiple sclerosis	0.001	0.0022	CcSEcCtD
Mepivacaine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.001	0.00219	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—PRNP—multiple sclerosis	0.001	0.00818	CbGpPWpGaD
Mepivacaine—Shock—Betamethasone—multiple sclerosis	0.000998	0.00219	CcSEcCtD
Mepivacaine—Shock—Dexamethasone—multiple sclerosis	0.000998	0.00219	CcSEcCtD
Mepivacaine—Agitation—Prednisone—multiple sclerosis	0.000995	0.00218	CcSEcCtD
Mepivacaine—Tachycardia—Dexamethasone—multiple sclerosis	0.00099	0.00217	CcSEcCtD
Mepivacaine—Tachycardia—Betamethasone—multiple sclerosis	0.00099	0.00217	CcSEcCtD
Mepivacaine—Angioedema—Prednisone—multiple sclerosis	0.000989	0.00217	CcSEcCtD
Mepivacaine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000981	0.00215	CcSEcCtD
Mepivacaine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000981	0.00215	CcSEcCtD
Mepivacaine—Syncope—Prednisone—multiple sclerosis	0.000971	0.00213	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—multiple sclerosis	0.000969	0.00212	CcSEcCtD
Mepivacaine—Urticaria—Prednisolone—multiple sclerosis	0.000966	0.00211	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisone—multiple sclerosis	0.000951	0.00208	CcSEcCtD
Mepivacaine—Hypotension—Betamethasone—multiple sclerosis	0.000948	0.00208	CcSEcCtD
Mepivacaine—Hypotension—Dexamethasone—multiple sclerosis	0.000948	0.00208	CcSEcCtD
Mepivacaine—Vomiting—Mitoxantrone—multiple sclerosis	0.000942	0.00206	CcSEcCtD
Mepivacaine—Convulsion—Prednisone—multiple sclerosis	0.000938	0.00205	CcSEcCtD
Mepivacaine—Hypertension—Prednisone—multiple sclerosis	0.000935	0.00205	CcSEcCtD
Mepivacaine—Chills—Methotrexate—multiple sclerosis	0.000932	0.00204	CcSEcCtD
Mepivacaine—Headache—Mitoxantrone—multiple sclerosis	0.000928	0.00203	CcSEcCtD
Mepivacaine—Anxiety—Prednisone—multiple sclerosis	0.000918	0.00201	CcSEcCtD
Mepivacaine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000911	0.00199	CcSEcCtD
Mepivacaine—Paraesthesia—Betamethasone—multiple sclerosis	0.000911	0.00199	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—multiple sclerosis	0.000905	0.00198	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000896	0.00196	CcSEcCtD
Mepivacaine—Urticaria—Triamcinolone—multiple sclerosis	0.000888	0.00194	CcSEcCtD
Mepivacaine—Urticaria—Methylprednisolone—multiple sclerosis	0.000886	0.00194	CcSEcCtD
Mepivacaine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000884	0.00193	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000883	0.00193	CcSEcCtD
Mepivacaine—Oedema—Prednisone—multiple sclerosis	0.000883	0.00193	CcSEcCtD
Mepivacaine—Nausea—Mitoxantrone—multiple sclerosis	0.00088	0.00193	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—multiple sclerosis	0.000875	0.00192	CcSEcCtD
Mepivacaine—Shock—Prednisone—multiple sclerosis	0.000869	0.0019	CcSEcCtD
Mepivacaine—Tachycardia—Prednisone—multiple sclerosis	0.000862	0.00189	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000854	0.00187	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—multiple sclerosis	0.000853	0.00187	CcSEcCtD
Mepivacaine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000824	0.0018	CcSEcCtD
Mepivacaine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000822	0.0018	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—PRNP—multiple sclerosis	0.000809	0.00662	CbGpPWpGaD
Mepivacaine—Urticaria—Betamethasone—multiple sclerosis	0.000806	0.00176	CcSEcCtD
Mepivacaine—Urticaria—Dexamethasone—multiple sclerosis	0.000806	0.00176	CcSEcCtD
Mepivacaine—Dizziness—Prednisolone—multiple sclerosis	0.000804	0.00176	CcSEcCtD
Mepivacaine—Asthenia—Triamcinolone—multiple sclerosis	0.000802	0.00176	CcSEcCtD
Mepivacaine—Body temperature increased—Betamethasone—multiple sclerosis	0.000802	0.00176	CcSEcCtD
Mepivacaine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000802	0.00176	CcSEcCtD
Mepivacaine—Asthenia—Methylprednisolone—multiple sclerosis	0.0008	0.00175	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisone—multiple sclerosis	0.000793	0.00174	CcSEcCtD
Mepivacaine—Pruritus—Triamcinolone—multiple sclerosis	0.000791	0.00173	CcSEcCtD
Mepivacaine—Pruritus—Methylprednisolone—multiple sclerosis	0.000789	0.00173	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—multiple sclerosis	0.000784	0.00172	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—PTPRC—multiple sclerosis	0.000778	0.00636	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—PRNP—multiple sclerosis	0.000774	0.00633	CbGpPWpGaD
Mepivacaine—Headache—Prednisolone—multiple sclerosis	0.000762	0.00167	CcSEcCtD
Mepivacaine—SCN2A—Axon guidance—PRNP—multiple sclerosis	0.000744	0.00608	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—PRNP—multiple sclerosis	0.000744	0.00608	CbGpPWpGaD
Mepivacaine—Dizziness—Triamcinolone—multiple sclerosis	0.000739	0.00162	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000738	0.00162	CcSEcCtD
Mepivacaine—Dizziness—Methylprednisolone—multiple sclerosis	0.000738	0.00161	CcSEcCtD
Mepivacaine—Asthenia—Dexamethasone—multiple sclerosis	0.000728	0.00159	CcSEcCtD
Mepivacaine—Asthenia—Betamethasone—multiple sclerosis	0.000728	0.00159	CcSEcCtD
Mepivacaine—Nausea—Prednisolone—multiple sclerosis	0.000722	0.00158	CcSEcCtD
Mepivacaine—Pruritus—Dexamethasone—multiple sclerosis	0.000718	0.00157	CcSEcCtD
Mepivacaine—Pruritus—Betamethasone—multiple sclerosis	0.000718	0.00157	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—PRNP—multiple sclerosis	0.000717	0.00586	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—PRNP—multiple sclerosis	0.000717	0.00586	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PRNP—multiple sclerosis	0.000714	0.00584	CbGpPWpGaD
Mepivacaine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000714	0.00156	CcSEcCtD
Mepivacaine—Vomiting—Triamcinolone—multiple sclerosis	0.000711	0.00156	CcSEcCtD
Mepivacaine—Vomiting—Methylprednisolone—multiple sclerosis	0.000709	0.00155	CcSEcCtD
Mepivacaine—Urticaria—Prednisone—multiple sclerosis	0.000702	0.00154	CcSEcCtD
Mepivacaine—Headache—Triamcinolone—multiple sclerosis	0.0007	0.00153	CcSEcCtD
Mepivacaine—Headache—Methylprednisolone—multiple sclerosis	0.000699	0.00153	CcSEcCtD
Mepivacaine—Body temperature increased—Prednisone—multiple sclerosis	0.000698	0.00153	CcSEcCtD
Mepivacaine—Hypotension—Methotrexate—multiple sclerosis	0.00069	0.00151	CcSEcCtD
Mepivacaine—Dizziness—Betamethasone—multiple sclerosis	0.000671	0.00147	CcSEcCtD
Mepivacaine—Dizziness—Dexamethasone—multiple sclerosis	0.000671	0.00147	CcSEcCtD
Mepivacaine—Nausea—Triamcinolone—multiple sclerosis	0.000664	0.00145	CcSEcCtD
Mepivacaine—Paraesthesia—Methotrexate—multiple sclerosis	0.000663	0.00145	CcSEcCtD
Mepivacaine—Nausea—Methylprednisolone—multiple sclerosis	0.000663	0.00145	CcSEcCtD
Mepivacaine—Somnolence—Methotrexate—multiple sclerosis	0.000656	0.00144	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisone—multiple sclerosis	0.000651	0.00142	CcSEcCtD
Mepivacaine—Vomiting—Betamethasone—multiple sclerosis	0.000645	0.00141	CcSEcCtD
Mepivacaine—Vomiting—Dexamethasone—multiple sclerosis	0.000645	0.00141	CcSEcCtD
Mepivacaine—Headache—Betamethasone—multiple sclerosis	0.000635	0.00139	CcSEcCtD
Mepivacaine—Headache—Dexamethasone—multiple sclerosis	0.000635	0.00139	CcSEcCtD
Mepivacaine—Asthenia—Prednisone—multiple sclerosis	0.000634	0.00139	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—PTPRC—multiple sclerosis	0.000629	0.00515	CbGpPWpGaD
Mepivacaine—Pruritus—Prednisone—multiple sclerosis	0.000625	0.00137	CcSEcCtD
Mepivacaine—Nausea—Dexamethasone—multiple sclerosis	0.000603	0.00132	CcSEcCtD
Mepivacaine—Nausea—Betamethasone—multiple sclerosis	0.000603	0.00132	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—PTPRC—multiple sclerosis	0.000602	0.00492	CbGpPWpGaD
Mepivacaine—Urticaria—Methotrexate—multiple sclerosis	0.000587	0.00128	CcSEcCtD
Mepivacaine—SCN8A—L1CAM interactions—MAPK1—multiple sclerosis	0.000586	0.00479	CbGpPWpGaD
Mepivacaine—Dizziness—Prednisone—multiple sclerosis	0.000584	0.00128	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—multiple sclerosis	0.000584	0.00128	CcSEcCtD
Mepivacaine—SCN4A—Axon guidance—PTPRC—multiple sclerosis	0.000578	0.00473	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—PTPRC—multiple sclerosis	0.000578	0.00473	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PRNP—multiple sclerosis	0.000577	0.00472	CbGpPWpGaD
Mepivacaine—Vomiting—Prednisone—multiple sclerosis	0.000562	0.00123	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—PTPRC—multiple sclerosis	0.000558	0.00456	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—PTPRC—multiple sclerosis	0.000558	0.00456	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PTPRC—multiple sclerosis	0.000555	0.00454	CbGpPWpGaD
Mepivacaine—Headache—Prednisone—multiple sclerosis	0.000553	0.00121	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—PRNP—multiple sclerosis	0.000552	0.00452	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000544	0.00119	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—PRNP—multiple sclerosis	0.000531	0.00434	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PRNP—multiple sclerosis	0.000531	0.00434	CbGpPWpGaD
Mepivacaine—Asthenia—Methotrexate—multiple sclerosis	0.00053	0.00116	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000525	0.00429	CbGpPWpGaD
Mepivacaine—Nausea—Prednisone—multiple sclerosis	0.000525	0.00115	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—multiple sclerosis	0.000522	0.00114	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—PRNP—multiple sclerosis	0.000512	0.00418	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PRNP—multiple sclerosis	0.000512	0.00418	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—PRNP—multiple sclerosis	0.000504	0.00412	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000501	0.0041	CbGpPWpGaD
Mepivacaine—Dizziness—Methotrexate—multiple sclerosis	0.000488	0.00107	CcSEcCtD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	0.000485	0.00396	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—MAPK1—multiple sclerosis	0.000474	0.00388	CbGpPWpGaD
Mepivacaine—Vomiting—Methotrexate—multiple sclerosis	0.000469	0.00103	CcSEcCtD
Mepivacaine—Headache—Methotrexate—multiple sclerosis	0.000463	0.00101	CcSEcCtD
Mepivacaine—SCN3A—L1CAM interactions—MAPK1—multiple sclerosis	0.000454	0.00371	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PTPRC—multiple sclerosis	0.000449	0.00367	CbGpPWpGaD
Mepivacaine—Nausea—Methotrexate—multiple sclerosis	0.000439	0.00096	CcSEcCtD
Mepivacaine—SCN4A—L1CAM interactions—MAPK1—multiple sclerosis	0.000436	0.00356	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—MAPK1—multiple sclerosis	0.000436	0.00356	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PTPRC—multiple sclerosis	0.000429	0.00351	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—MAPK1—multiple sclerosis	0.00042	0.00344	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—MAPK1—multiple sclerosis	0.00042	0.00344	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PTPRC—multiple sclerosis	0.000413	0.00337	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PTPRC—multiple sclerosis	0.000413	0.00337	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PTPRC—multiple sclerosis	0.000398	0.00325	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PTPRC—multiple sclerosis	0.000398	0.00325	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—PTPRC—multiple sclerosis	0.000392	0.00321	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PRNP—multiple sclerosis	0.00036	0.00294	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—TYK2—multiple sclerosis	0.000348	0.00285	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.000295	0.00242	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—TYK2—multiple sclerosis	0.000282	0.0023	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	0.00028	0.00229	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MMP9—multiple sclerosis	0.000274	0.00224	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—TYK2—multiple sclerosis	0.000269	0.0022	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000263	0.00215	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—TYK2—multiple sclerosis	0.000259	0.00212	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—TYK2—multiple sclerosis	0.000259	0.00212	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—TYK2—multiple sclerosis	0.000249	0.00204	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—TYK2—multiple sclerosis	0.000249	0.00204	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TYK2—multiple sclerosis	0.000248	0.00203	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP9—multiple sclerosis	0.000222	0.00181	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MAPK1—multiple sclerosis	0.000222	0.00181	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP9—multiple sclerosis	0.000212	0.00173	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP9—multiple sclerosis	0.000204	0.00167	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP9—multiple sclerosis	0.000204	0.00167	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TYK2—multiple sclerosis	0.000201	0.00164	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP9—multiple sclerosis	0.000196	0.00161	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP9—multiple sclerosis	0.000196	0.00161	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP9—multiple sclerosis	0.000196	0.0016	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TYK2—multiple sclerosis	0.000192	0.00157	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000191	0.00156	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TYK2—multiple sclerosis	0.000185	0.00151	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TYK2—multiple sclerosis	0.000185	0.00151	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MAPK1—multiple sclerosis	0.000179	0.00147	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TYK2—multiple sclerosis	0.000178	0.00146	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TYK2—multiple sclerosis	0.000178	0.00146	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—TYK2—multiple sclerosis	0.000175	0.00143	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—STAT3—multiple sclerosis	0.000174	0.00142	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MAPK1—multiple sclerosis	0.000171	0.0014	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—multiple sclerosis	0.00017	0.00139	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MAPK1—multiple sclerosis	0.000165	0.00135	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MAPK1—multiple sclerosis	0.000165	0.00135	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TGFB1—multiple sclerosis	0.000161	0.00132	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAPK1—multiple sclerosis	0.000159	0.0013	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAPK1—multiple sclerosis	0.000159	0.0013	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP9—multiple sclerosis	0.000158	0.00129	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAPK1—multiple sclerosis	0.000158	0.00129	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000154	0.00126	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP9—multiple sclerosis	0.000151	0.00124	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TNF—multiple sclerosis	0.000151	0.00123	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP9—multiple sclerosis	0.000145	0.00119	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP9—multiple sclerosis	0.000145	0.00119	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—STAT3—multiple sclerosis	0.000141	0.00115	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP9—multiple sclerosis	0.00014	0.00115	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP9—multiple sclerosis	0.00014	0.00115	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP9—multiple sclerosis	0.000138	0.00113	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—multiple sclerosis	0.000138	0.00113	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—STAT3—multiple sclerosis	0.000135	0.0011	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—multiple sclerosis	0.000132	0.00108	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TGFB1—multiple sclerosis	0.00013	0.00107	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—STAT3—multiple sclerosis	0.000129	0.00106	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—STAT3—multiple sclerosis	0.000129	0.00106	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAPK1—multiple sclerosis	0.000128	0.00105	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—multiple sclerosis	0.000127	0.00103	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—multiple sclerosis	0.000127	0.00103	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TYK2—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TGFB1—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—STAT3—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—STAT3—multiple sclerosis	0.000125	0.00102	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK1—multiple sclerosis	0.000122	0.001	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—multiple sclerosis	0.000122	0.000998	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—multiple sclerosis	0.000122	0.000998	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TNF—multiple sclerosis	0.000122	0.000996	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—multiple sclerosis	0.000121	0.000994	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	0.00012	0.00098	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TGFB1—multiple sclerosis	0.00012	0.00098	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK1—multiple sclerosis	0.000118	0.000961	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	0.000118	0.000961	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TNF—multiple sclerosis	0.000116	0.000952	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TGFB1—multiple sclerosis	0.000116	0.000945	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TGFB1—multiple sclerosis	0.000116	0.000945	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAPK1—multiple sclerosis	0.000113	0.000927	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK1—multiple sclerosis	0.000113	0.000927	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TNF—multiple sclerosis	0.000112	0.000915	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TNF—multiple sclerosis	0.000112	0.000915	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAPK1—multiple sclerosis	0.000112	0.000913	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TNF—multiple sclerosis	0.000108	0.000882	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TNF—multiple sclerosis	0.000108	0.000882	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP9—multiple sclerosis	9.86e-05	0.000806	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—multiple sclerosis	9.83e-05	0.000804	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—multiple sclerosis	9.4e-05	0.000769	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—multiple sclerosis	9.03e-05	0.000738	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—multiple sclerosis	9.03e-05	0.000738	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—STAT3—multiple sclerosis	8.76e-05	0.000717	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—multiple sclerosis	8.71e-05	0.000712	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—multiple sclerosis	8.71e-05	0.000712	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—multiple sclerosis	8.58e-05	0.000701	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	8.12e-05	0.000664	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	7.97e-05	0.000651	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TNF—multiple sclerosis	7.59e-05	0.00062	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—multiple sclerosis	6.12e-05	0.000501	CbGpPWpGaD
